Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-031/4412
C07D-213/62
출원번호
US-0895985
(2004-07-22)
등록번호
US-8637553
(2014-01-28)
발명자
/ 주소
Boyer, Stephen
Dumas, Jacques
Riedl, Bernd
Wilhelm, Scott
출원인 / 주소
Bayer Healthcare LLC
대리인 / 주소
Millen, White, Zelano & Branigan, P.C.
인용정보
피인용 횟수 :
6인용 특허 :
217
초록
A compound of Formula (I): salts thereof, prodrugs thereof, metabolites thereof, pharmaceutical compositions containing such a compound, and use of such compound and compositions to treat diseases mediated by raf, VEGFR, PDGFR, p38 and flt-3.
대표청구항▼
1. A compound of Formula (I) or a pharmaceutically acceptable salt thereof, or an isolated stereoisomer of a pharmaceutically acceptable salt thereof 2. A pharmaceutically acceptable salt of a compound of Formula I which is a basic salt of an organic acid or inorganic acid which is hydrochloric ac
1. A compound of Formula (I) or a pharmaceutically acceptable salt thereof, or an isolated stereoisomer of a pharmaceutically acceptable salt thereof 2. A pharmaceutically acceptable salt of a compound of Formula I which is a basic salt of an organic acid or inorganic acid which is hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, methanesulfonic acid, trifluoromethanesulfonic acid, benzenesulfonic acid, p-toluene sulfonic acid (tosylate salt), 1-napthalene sulfonic acid, 2-napthalene sulfonic acid, acetic acid, trifluoroacetic acid, malic acid, tartaric acid, citric acid, lactic acid, oxalic acid, succinic acid, fumaric acid, maleic acid, benzoic acid, salicylic acid, phenylacetic acid, or mandelic acid. 3. A compound which is 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide, or a pharmaceutically acceptable salt thereof. 4. A pharmaceutically acceptable salt of a compound of claim 3 which is a basic salt of an organic acid or inorganic acid which is hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, methanesulfonic acid, trifluoromethanesulfonic acid, benzenesulfonic acid, p-toluene sulfonic acid (tosylate salt), 1-napthalene sulfonic acid, 2-napthalene sulfonic acid, acetic acid, trifluoroacetic acid, malic acid, tartaric acid, citric acid, lactic acid, oxalic acid, succinic acid, fumaric acid, maleic acid, benzoic acid, salicylic acid, phenylacetic acid, or mandelic acid. 5. A compound which is a hydrochloride, benzenesulfonate, or methanesulfonate salt of N-(4-chloro-3-(trifluoromethyl)phenyl)-N′-2-fluoro-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl) urea. 6. A pharmaceutical composition comprising a compound of claim 1 and a physiologically acceptable carrier. 7. A pharmaceutical composition comprising a compound of claim 2 and a physiologically acceptable carrier. 8. A pharmaceutical composition comprising a compound of claim 3 and a physiologically acceptable carrier. 9. A pharmaceutical composition which comprises a pharmaceutically acceptable salt of N-(4-chloro-3-(trifluoromethyl)phenyl)-N′-2-fluoro-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl) urea and a physiologically acceptable carrier. 10. A compound which is a metabolite of the compound of Formula (I) or a pharmaceutically acceptable salt thereof, or an isolated stereoisomer of a pharmaceutically acceptable salt thereof, where the metabolism site is either one of the two urea nitrogen atoms, or the pyridine nitrogen atom, or the methylamide functionality, or any combination of the above. 11. A compound of which is a metabolite of the compound of Formula (I), where a) either urea nitrogen atom carries a hydroxyl group, orb) the pyridine nitrogen atom is oxidized, orc) the amide functionality is de-methylated, ord) the pyridine nitrogen atom is oxidized and the amide functionality is de-methylated, ore) either urea nitrogen atom carries a hydroxyl group and the pyridine nitrogen atom is oxidized, orf) either urea nitrogen atom carries a hydroxyl group and the amide functionality is de-methylated, org) either urea nitrogen atom carries a hydroxyl group and the pyridine nitrogen atom is oxidized and the amide functionality is de-methylated. 12. A compound which is: 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid amide,4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-1-hydroxy-pyridine-2-carboxylic acid methylamide, or4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-1-hydroxy-pyridine-2-carboxylic acid amide. 13. A compound of Formula (I) 14. A pharmaceutical composition comprising the compound of claim 13 and a physiologically acceptable carrier. 15. A salt of a compound of Formula (I) 16. A pharmaceutical composition comprising a salt of claim 15 and a physiologically acceptable carrier.
Vladi{acute over (m)}ir Oremus SK; Vendelin {haeck over (S)}mahovsky SK; Viera Faberova SK; Ivan Kakalik SK; {haeck over (L)}udmila Schmidtova SK; Marian Zemanek SK, 1,3-disubstituted ureas as ACAT inhibitors, and method of preparing thereof.
Aldrich Paul Edward (Wilmington DE) Berezin Gilbert Harvey (West Chester PA) Dittmar Bruce Ivor (Wilmington DE), 1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agen.
Paolo Pevarello IT; Paolo Orsini IT; Gabriella Traquandi IT; Mario Varasi IT; Edward L. Fritzen ; Martha A. Warpehoski ; Betsy S. Pierce, 3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents.
Dixon James S. (Malvern PA) Hall Raplh F. (Villanova PA) Marshall Lisa A. (Wyndmoor PA) Chilton ; III Floyd H. (Pilot Mountain NC) Mayer Ruth J. (Wayne PA) Winkler James D. (Fort Washington PA), Anti-inflammatory compounds.
John C. Lee ; Jerry L. Adams ; Timothy F. Gallagher ; David W. Green ; John Richard Heys ; Peter C. McDonnell ; Dean E. McNulty ; Peter R. Young ; James E. Strickler, Antibodies produced against cytokine suppressive anti-inflammatory drug binding proteins.
O\Doherty George O. P. (Greenfield IN) Clinton Albert J. (Indianapolis IN), Anticoccidial combinations comprising polyether antibiotics and carbanilides.
O\Doherty George O. P. (Greenfield IN) Clinton Albert J. (Indianapolis IN), Anticoccidial combinations comprising polyether antibiotics and carbanilides.
Boder George B. (Martinsville IN) Ehlhardt William J. (Indianapolis IN) Grindey Gerald B. (Indianapolis IN) Toth John E. (Indianapolis IN) Worzalla John F. (Indianapolis IN) Zimmermann John L. (Green, Antitumor compositions and methods.
Regan John R. ; Cirillo Pier F. ; Hickey Eugene R. ; Moss Neil ; Cywin Charles L. ; Pargellis Christopher ; Gilmore Thomas A., Aromatic heterocyclic compounds and their use as anti-inflammatory agents.
Regan John R. ; Cirillo Pier F. ; Hickey Eugene R. ; Moss Neil ; Cywin Charles L. ; Pargellis Christopher ; Gilmore Thomas A., Aromatic heterocyclic compounds and their use as anti-inflammatory agents.
Cirillo, Pier Francesco; Dinallo, Roger; Regan, John Robinson; Riska, Paul S.; Swinamer, Alan David; Tan, Zhulin; Walter, Brian Andrew, Aromatic heterocyclic compounds as antiinflammatory agents.
Reel Jon K. (Carmel IN) Simon Richard L. (Greenwood IN) Whitesitt Celia A. (Greenwood IN), Chemical compounds as inhibitors of amyloid beta protein production.
Sirrenberg ; Wilhelm ; Alles ; Hans-Ulrich ; Hammann ; Ingeborg ; Stend el ; Wilhelm, Combating arthropods with 3-(2,2,4,4-tetrafluoro-benz-1,3-dioxin-6-yl)-1-(substituted benzoyl)-ureas.
Petrie Charles ; Orme Mark W. ; Baindur Nand ; Robbins Kirk G. ; Kontoyianni Maria ; Mundy Gregory R., Compositions and methods for treating bone deficit conditions.
Steffen Breitfelder ; Pier F. Cirillo ; Thomas A. Gilmore ; Eugene R. Hickey ; John R. Proudfoot ; John R. Regan ; Alan D. Swinamer ; Hidenori Takahashi, Compounds useful as anti-inflammatory agents.
Lee John C. ; Adams Jerry L. ; Gallagher Timothy F. ; Green David W. ; Heys John Richard ; McDonnell Peter C. ; McNulty Dean E. ; Strickler James E. ; Young Peter R., Cytokine suppressive anit-inflammatory drug binding proteins.
Charles R. Petrie ; Patricia A. McKernan ; Emma E. Moore ; John M. Ostresh ; Jean-Philippe Meyer ; Richard A. Houghten ; Clemencia Pinilla, Dialkyl ureas as calcitonin mimetics.
Acker Rolf-Dieter (Leimen DEX) Rossy Phillip A. (Ludwigshafen DEX) Hamprecht Gerhard (Weinheim DEX) Wuerzer Bruno (Otterstadt DEX), Dihydrothiophenecarboxylates and their use for controlling undersirable plant growth.
Shaughnessy,John D.; Barlogie,Bart; Zhan,Fenghuang, Gene expression profiling based identification of DKK1 as a potential therapeutic targets for controlling bone loss.
Tracey, Kevin J.; Cohen, Pamela; Bukrinsky, Michael; Schmidtmayerova, Helena, Guanylhydrazones useful for treating diseases associated with T cell activation.
Widdowson Katherine Louisa ; Veber Daniel Frank ; Jurewicz Anthony Joseph ; Hertzberg Robert Philip ; Rutledge ; Jr. Melvin Clarence, IL-8 receptor antagonists.
Widdowson Katherine Louisa ; Veber Daniel Frank ; Jurewicz Anthony Joseph ; Hertzberg Robert Philip ; Rutledge ; Jr. Melvin Clarence, IL-8 receptor antagonists.
Widdowson Katherine Louisa ; Veber Daniel Frank ; Jurewicz Anthony Joseph ; Hertzberg Robert Philip ; Rutledge ; Jr. Melvin Clarence, IL-8 receptor antagonists.
Widdowson Katherine Louisa ; Veber Daniel Frank ; Jurewicz Anthony Joseph ; Hertzberg Robert Philip ; Rutledge ; Jr. Melvin Clarence, IL-8 receptor antagonists.
Widdowson Katherine Louisa ; Veber Daniel Frank ; Jurewicz Anthony Joseph ; Hertzberg Robert Phillip ; Rutledge ; Jr. Melvin Clarence, IL-8 receptor antagonists.
Adams Jerry Leroy (Wayne PA) Gallagher Timothy Francis (Harleysville PA) Sisko Joseph (Hatfield PA) Peng Zhi-Qiang (King of Prussia PA) Osifo Irennegbe Kelly (Eagleville PA) Boehm Jeffrey Charles (Ki, Imidazole compounds, compositions and use.
Dumas, Jacques; Riedl, Bernd; Khire, Uday; Wood, Jill E.; Sibley, Robert N.; Monahan, Mary-Katherine; Renick, Joel; Gunn, David E.; Lowinger, Timothy B.; Scott, William J.; Smith, Roger A., Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas.
Gerald Ranges ; William Scott ; Michael Bombara ; Deborah Rauner ; Aniko Redman ; Roger Smith ; Holger Paulsen DE; David Gunn ; Jinshan Chen ; Joel Renick, Inhibition of p38 kinase activity by aryl ureas.
Bonjouklian Rosanne (Zionsville IN) Dodge Jeffrey A. (Indianapolis IN) Vlahos Chris J. (Carmel IN), Inhibition of phosphatidylinositol 3-kinase with 17 b
상세보기
Dodge Jeffrey A. ; Sato Masahiko ; Vlahos Chris J., Inhibition of phosphatidylinositol 3-kinase with viridin, demethoxyviridin, viridiol, demethoxyviridiol, virone, wortma.
Bonjouklian Rosanne (Zionsville IN) Vlahos Chris J. (Carmel IN) Powis Garth (Tucson AZ), Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof.
Wood Jill E ; Wild Hanno,DEX ; Rogers Daniel H ; Lyons John ; Katz Michael ; Caringal Yolanda ; Dally Robert ; Lee Wendy ; Smith Roger A. ; Blum Cheri, Inhibition of raf kinase activity using aryl ureas.
Armistead David M. ; Badia Michael C. ; Bemis Guy W. ; Bethiel Randy S. ; Frank Catharine A. ; Novak Perry M. ; Ronkin Steven M. ; Saunders Jeffrey O., Inhibitors of IMPDH enzyme.
Heinz Lawrence J. ; Panetta Jill A. ; Phillips Michael L. ; Reel Jon K. ; Shadle John K. ; Simon Richard L. ; Whitesitt Celia A., Inhibitors of amyloid beta-protein production.
Kabbe Hans-Joachim (Leverkusen DEX) Klauke Erich (Odenthal DEX) Krause Hans P. (Wuppertal DEX) Mardin Mithat (Wuppertal DEX) Sitt Rdiger (Wuppertal DEX), Medicaments for the treatment of disorders of lipometabolism and their use.
Warenius, Hilmar Meek; Seabra, Laurence Anthony, Methods for determining chemosensitivity of cancer cells based upon expression of negative and positive signal transduction factors.
Dodge Jeffrey A. (Indianapolis IN) Sato Masahiko (Carmel IN), Methods for inhibiting bone loss and cartilage degradation using wortmannin and its analogs.
Tang Peng C. ; McMahon Gerald ; Weinberger Heinz,DEX ; Kutscher Bernhard,DEX ; App Harald, Methods of modulating serine/thereonine protein kinase function with quinazoline-based compounds.
Foulkes J. Gordon ; Leichtfried Franz ; Pieler Christian ; Stephenson John R., Methods of specifically transcriptionally modulating the expression of gene of interest.
Bger Manfred (Weil am Rhein DEX) Ehrenfreund Josef (Allschwil CHX) Martin Pierre (Rheinfelden CHX) Steiner Eginhard (Fllinsdorf CHX), N-(2-Pyridyloxyphenyl)-N′-benzoyl ureas, pesticidal compositions containing same and pesticidal methods of use.
Schlegel Donald C. (Schodack NY) Johnson Robert E. (East Greenbush NY), N-(w
상세보기
Hisashi Kanno JP; Yoshikazu Kubota JP; Tsutomu Sato JP; Koki Sato JP, N-(unsubstituted or substituted)-4-substituted-6-(unsubstituted or substituted)phenoxy-2-pyridinecarboxamides or thiocarboxamides, processes for producing the same, and herbicides.
Ko, Soo S.; DeLucca, George V.; Duncia, John V.; Santella, III, Joseph B.; Gardner, Daniel S., N-ureidoalkyl-piperidines as modulators of chemokine receptor activity.
Lepage Francis (Creteil FRX) Hublot Bernard (Paris FRX), Novel isoxazole and isoxazoline compounds with anticonvulsant activity process for their preparation and therapeutic com.
Goulet Mark (Westfield NJ) Parsons William H. (Edison NJ) Sinclair Peter J. (Highland Park NJ) Wong Frederick (Glen Ridge NJ) Wyvratt Matthew J. (Mountainside NJ), O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives.
Lee John C. ; Adams Jerry L. ; Gallagher Timothy F. ; Green David W. ; Heys John Richard ; McDonnell Peter C. ; McNulty Dean E. ; Young Peter R. ; Strickler James E., Oligonucleotides comprising a region of a cytokine suppressive anti-inflammatory drug binding protein.
Hider Robert C. (Clacton GB2) Kontoghiorghes George (London GB2) Silver Jack (London GB2) Stockham Michael A. (Saffron Walden GB2), Pharmaceutical compositions.
Caldwell, William Scott; Bencherif, Merouane; Dull, Gary Maurice; Crooks, Peter Anthony; Lippiello, Patrick Michael, Pharmaceutical compositions and methods for effecting dopamine release.
Widdowson Katherine Louisa ; Veber Daniel Frank ; Jurewicz Anthony Joseph ; Hertzberg Robert Philip ; Rutledge ; Jr. Melvin Clarence, Phenyl urea antagonists of the IL-8 receptor.
Barbachyn Michael Robert ; Homa Fred L. ; Monge Antonio,ESX ; Santiago Esteban,ESX ; Martinez-Irujo Juan J.,ESX ; Font Maria,ESX, Polyaromatic antiviral compositions.
Lee John C. ; Adams Jerry L. ; Gallagher Timothy F. ; Green David W. ; Heys John Richard ; McDonnell Peter C. ; McNulty Dean E. ; Strickler James E. ; Young Peter R., Polynucleotides encoding cytokine suppressive anti-inflammatory drug binding proteins.
Kissener Wolfram (Bergisch Gladbach DEX) Franke Joachim (Cologne DEX) Fiege Helmut (Leverkusen DEX) Wedemeyer Karlfried (Cologne DEX), Process for the preparation of N,N-diaryl-ureas.
Trk Sandor (Budapest HUX) Vrshazy Lajos (Budapest HUX) Galambos Peter (Budapest HUX) Daroczi Ivan (Budapest HUX) Ormenyi Zoltan (Budapest HUX), Process for the preparation of N-aryl-N′-(mono- or di substituted)-urea derivatives.
Myers Michael R. ; Spada Alfred P. ; Maguire Martin P. ; Persons Paul E., Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylati.
Lee John Cheung-Lun ; Adams Jerry Leroy ; Gallagher Timothy Francis ; Green David W. ; Heys John Richard ; McDonnell Peter Colon ; McNulty Dean Edward ; Strickler James E. ; Young Peter Ronald, Screening methods using cytokine suppressive anti-inflammatory drug (CSAID) binding proteins.
Kleemann Heinz-Werner (Bischofsheim DEX) Lang Hans-Jochen (Hofheim DEX) Schwark Jan-Robert (Frankfurt DEX) Weichert Andreas (Egelsbach DEX) Scholz Wolfgang (Eschborn DEX) Albus Udo (Florstadt DEX), Substituted N-heteroaroylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and.
Peter Charles Astles GB; David Edward Clark GB; Alan John Collis GB; Paul Joseph Cox GB; Paul Robert Eastwood GB; Neil Victor Harris GB; Justine Yeun Quai Lai GB; Andrew David Morley GB; Barr, Substituted anilides.
Ashton Wallace T. (Clark NJ) Chang Linda L. (Wayne NJ) Greenlee William J. (Teaneck NJ) Hutchins Steven M. (Iselin NJ) Rivero Ralph A. (Tinton Falls NJ), Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines.
Hallenbach Werner (Langenfeld DEX) Lindel Hans (Leverkusen DEX) Berschauer Friedrich (Wuppertal DEX) Scheer Martin (Wuppertal DEX) de Jong Anno (Wuppertal DEX), Thienooxazinones, processes for their preparation, and their use as growth promoters.
Nishiyama, Ryuzo; Fujikawa, Kanichi; Yokomichi, Isao; Haga, Takahiro; Nagatani, Kuniaki; Hayashi, Kouji, Trifluoromethyl-2-pyridinone or pyridinthione compounds and process for the preparation of the same.
Ullrich Axel,DEX ; Risau Werner,DEX ; Millauer Birgit,DEX, Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis.
Hallenbach Werner (Langenfeld DEX) Lindel Hans (Leverkusen DEX) Brandes Wilhelm (Leichlingen DEX), Use of thienylurea derivatives as selective fungicides.
Stiehl, Juergen; Heilmann, Werner; Lögers, Michael; Rehse, Joachim; Gottfried, Michael; Wichmann, Saskia, Process for the preparation of 4-{4-[({[4 chloro-3-(trifluoromethyl)-phenyl]amino}carbonyl)amino]-3-fluorphenoxy-N-ethylpyridie-carboxamide, its salts and monohydrate.
Rampalli, Sriram; Upalla, Lav Kumar; Ramachandrula, Krishna Kumar; Purohit, Prashant; Akshay Kant, Chaturvedi, Process for the preparation of regorafenib and its crystalline forms.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.